Unregulated stem cell clinics pose risks as longevity market grows

The article highlights that many clinics offering stem cell therapies for longevity lack proven efficacy and regulatory oversight, posing serious risks to patients. This underscores a regulatory gap in the growing longevity sector, with implications for public health and consumer protection.